Ep-CAM Expression in Esophageal Cancer: A Potential Target for Therapy
Author Information
Author(s): Stoecklein Nikolas H, Siegmund Annika, Scheunemann Peter, Luebke Andreas M, Erbersdobler Andreas, Verde Pablo E, Eisenberger Claus F, Peiper Matthias, Rehders Alexander, Esch Jan Schulte am, Knoefel Wolfram Trudo, Hosch Stefan B
Primary Institution: Universitätsklinikum Düsseldorf
Hypothesis
To evaluate the expression and test the clinical significance of Ep-CAM in esophageal squamous cell carcinoma.
Conclusion
Ep-CAM may serve as a promising target for immunotherapy in esophageal squamous cell carcinoma.
Supporting Evidence
- 79% of tumors showed Ep-CAM neo-expression.
- 3+ Ep-CAM expression was linked to significantly decreased median relapse-free survival.
- Ep-CAM 3+ expression was identified as an independent prognostic factor.
Takeaway
This study found that a protein called Ep-CAM is often present in esophageal cancer and could help doctors create better treatments.
Methodology
Immunohistochemical analysis of Ep-CAM expression in tumor samples from 70 patients with esophageal SCC.
Limitations
The study's results are preliminary and need confirmation in a larger independent cohort.
Participant Demographics
70 patients with resectable esophageal carcinoma, including both male and female participants.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website